Super Fund Lookup is the ATO's external register of Self-Managed Super Funds' (SMSF) current compliance statuses. Employers can utilise this service to determine whether employer contributions qualify as superannuation guarantee payments.
Valsartan and hydrochlorothiazide is manufactured by Novartis Pharmaceuticals. Valsartan and hydrochlorothiazide is a combination of two medicines -- valsartan and hydrochlorothiazide. Valsartan is a newer type of blood pressure medicine known as an angiotensin II receptor blocker, or ARB for short.
The typical initial dose of valsartan in adults in 80 to 160 mg once daily, and it is used long term. Valsartan is also available in fixed combinations with hydrochlorothiazide (Diovan-HCT), amlodipine (Exforge and Exforge HCT) and aliskiren (Valturna).